Orthofix International | OFIX - 资产



金融业
股票价格
USD
资产
USD 873.02M
现金及等价物
USD 103.81M
销售成本
USD 66.63M
流动资产
USD 446.13M
流动负债
USD 157.01M
债务
USD 137.24M
股息收益率
0
EBIT
USD 6.12M
EBITDA
USD 27.88M
员工
1.09K
EPS每股收益
USD 0.09
股本和储备
USD 429.18M
销售毛利
USD 153.28M
债务利息支出
4.68M
贷款资金
USD 221.59M
市值
USD 348.3M
净收入
USD -2.22M
营业费用
USD 213.79M
营业利润
USD 6.12M
普通股股本
USD 39.83M
PE价格收益
4.17K
税前利润
USD -2.19M
销售收入
USD 219.91M
销售和管理费用
USD 130.35M
股票
USD 184.48M
贸易债权人
USD 63.53M
应收帐款人
USD 135.75M


资产 更改 日
Accuray USD 448.01M 8.81M 2025-12
AngioDynamics USD 269.68M 4.04M 2025-09
Artivion USD 1.07B 188.78M 2026-06
AtriCure USD 676.64M 32.66M 2026-06
Dexcom USD 6.46B 178M 2026-06
EDAP TMS EUR 72.06M 10.6M 2026-03
Globus Medical USD 5.49B 48.7M 2026-06
Inogen USD 307.01M 5.03M 2025-09
Insulet USD 3.17B 177.9M 2026-06
Integra LifeSciences USD 3.56B 14.24M 2026-06
J&J USD 201.06B 167M 2026-06
Medtronic USD 93.03B 1.54B 2026-03
Mesa Laboratories USD 434.85M 4.5M 2025-12
Orthofix International USD 873.02M 13.58M 2026-06
Plus Therapeutics USD 14.03M 5.89M 2026-06
Smith & Nephew USD 11.01B 321M 2026-06
STAAR Surgical USD 475.2M 24.09M 2026-06
Stryker USD 47.93B 1.64B 2026-06
Tandem Diabetes Care USD 1.15B 808K 2026-06
Teleflex USD 6.79B 3.78M 2026-06
Veracyte USD 1.49B 49.97M 2026-06
Zimmer Biomet Holdings USD 22.8B 76.2M 2026-06